Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

(Mark One)

     
x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the quarterly period ended June 30, 2003
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED]

Commission File Number 001-31225


ENPRO INDUSTRIES, INC.

(Exact name of registrant, as specified in its charter)
     
North Carolina
(State or other jurisdiction of incorporation)
  01-0573945
(I.R.S. Employer Identification No.)
     
5605 Carnegie Boulevard, Suite 500, Charlotte,
North Carolina

(Address of principal executive offices)
  28209
(Zip Code)
 
(704) 731-1500
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  x  No  o

Indicate by check mark whether the registrant is an accelerated filer (as defined by Rule 12b-2 of the Securities Exchange Act of 1934).

Yes  o  No  x

As of August 6, 2003, there were 20,453,647 shares of common stock of the registrant outstanding. There is only one class of common stock.


 

PART I, ITEM 1.

PART I. FINANCIAL INFORMATION
ENPRO INDUSTRIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Quarters and Six Months Ended June 30, 2003 and 2002
(In millions, except per share amounts)

                                   
      Quarters Ended June 30,   Six Months Ended June 30,
     
 
      2003   2002   2003   2002
     
 
 
 
Sales
  $ 198.3     $ 191.2     $ 382.3     $ 358.5  
Operating costs and expenses:
                               
 
Cost of sales
    137.9       133.4       265.2       250.2  
 
Selling, general and administrative expenses
    39.6       40.7       80.7       75.6  
 
Asbestos-related expenses
    2.5       1.8       5.4       7.0  
 
Restructuring costs
    0.4       1.1       0.5       2.0  
 
   
     
     
     
 
 
    180.4       177.0       351.8       334.8  
 
   
     
     
     
 
Operating income
    17.9       14.2       30.5       23.7  
Interest expense – net
    (2.0 )     (3.2 )     (3.9 )     (9.8 )
Mark-to-market adjustment for call options
    1.0       (5.1 )     (0.2 )     (5.1 )
Other income (expenses)
    0.5       (25.2 )     0.5       (25.2 )
 
   
     
     
     
 
Income (loss) before income taxes and distributions on convertible preferred securities of trust
    17.4       (19.3 )     26.9       (16.4 )
Income tax (expense) benefit
    (6.0 )     8.5       (9.4 )     7.4  
Distributions on convertible preferred securities of trust
          (1.3 )           (3.3 )
 
   
     
     
     
 
Income (loss) from continuing operations
    11.4       (12.1 )     17.5       (12.3 )
Income from discontinued operations, net of taxes
          10.8             24.2  
 
   
     
     
     
 
Income (loss) before cumulative effect of a change in accounting principle
    11.4       (1.3 )     17.5       11.9  
Cumulative effect of a change in accounting principle, net of taxes
                      (14.6 )
 
   
     
     
     
 
Net income (loss)
  $ 11.4     $ (1.3 )   $ 17.5     $ (2.7 )
 
   
     
     
     
 
Basic earnings per share:
                               
 
Continuing operations
  $ 0.57     $ (0.60 )   $ 0.87     $ (0.61 )
 
Discontinued operations
          0.54             1.20  
 
Cumulative effect of a change in accounting principle
                      (0.73 )
 
   
     
     
     
 
 
Net income (loss)
  $ 0.57     $ (0.06 )   $ 0.87     $ (0.14 )
 
   
     
     
     
 
Diluted earnings per share:
                               
 
Continuing operations
  $ 0.56     $ (0.60 )   $ 0.86     $ (0.61 )
 
Discontinued operations
          0.54             1.20  
 
Cumulative effect of a change in accounting principle
                      (0.73 )
 
   
     
     
     
 
 
Net income (loss)
  $ 0.56     $ (0.06 )   $ 0.86     $ (0.14 )
 
   
     
     
     
 

See notes to condensed consolidated financial statements (unaudited).

1


 

ENPRO INDUSTRIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Six Months Ended June 30, 2003 and 2002
(In millions)

                     
        2003   2002
       
 
OPERATING ACTIVITIES
               
 
Income (loss) from continuing operations
  $ 17.5     $ (12.3 )
 
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities of continuing operations:
               
   
Mark-to-market adjustment for call options
    0.2       5.1  
   
Non-operating (income) expenses
    (0.5 )     25.2  
   
Payments for asbestos-related claims, net of insurance proceeds
    (17.7 )     (42.7 )
   
Depreciation and amortization
    15.6       15.3  
   
Deferred income taxes
    5.0       4.5  
   
Increase in working capital
    (14.6 )     (7.9 )
   
Change in other non-current assets and liabilities
    (4.0 )     (6.4 )
 
 
   
     
 
 
Net cash provided by (used in) operating activities of continuing operations
    1.5       (19.2 )
 
 
   
     
 
INVESTING ACTIVITIES
               
 
Purchases of property, plant and equipment
    (6.6 )     (10.3 )
 
Proceeds from sales of assets
    1.6        
 
Purchase of call options
          (16.2 )
 
Receipt (payment) in connection with acquisitions
    (2.5 )     3.7  
 
 
   
     
 
 
Net cash used in investing activities of continuing operations
    (7.5 )     (22.8 )
 
 
   
     
 
FINANCING ACTIVITIES
               
 
Net additions to (repayment of) debt
    4.5       (0.4 )
 
Proceeds from issuance of common stock
    0.2        
 
Distributions on convertible preferred securities of trust
          (3.9 )
 
Net transfers (to) from Goodrich
    (0.6 )     54.3  
 
 
   
     
 
 
Net cash provided by financing activities of continuing operations
    4.1       50.0  
 
 
   
     
 
DISCONTINUED OPERATIONS
               
 
Net cash provided by discontinued operations
          13.0  
 
 
   
     
 
Effect of exchange rate changes on cash and cash equivalents
    1.7       1.2  
 
 
   
     
 
Net increase (decrease) in cash and cash equivalents
    (0.2 )     22.2  
Cash and cash equivalents at beginning of period
    81.8       25.9  
 
 
   
     
 
Cash and cash equivalents at end of period
  $ 81.6     $ 48.1  
 
 
   
     
 

See notes to condensed consolidated financial statements (unaudited).

2


 

ENPRO INDUSTRIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In millions, except share amounts)

                     
        June 30,   December 31,
        2003   2002
       
 
ASSETS
               
Current assets
               
 
Cash and cash equivalents
  $ 81.6     $ 81.8  
 
Accounts and notes receivable
    110.6       92.8  
 
Asbestos insurance receivable
    88.1       90.0  
 
Inventories
    60.3       61.9  
 
Other current assets
    22.5       22.4  
 
 
   
     
 
   
Total current assets
    363.1       348.9  
Property, plant and equipment
    132.6       136.0  
Goodwill and identifiable intangible assets
    185.4       185.0  
Asbestos insurance receivable
    184.2       205.9  
Other assets
    81.6       79.5  
 
 
   
     
 
   
Total assets
  $ 946.9     $ 955.3  
 
 
   
     
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities
               
 
Current maturities of long-term debt
  $ 0.4     $ 0.4  
 
Accounts payable
    43.1       43.0  
 
Asbestos liability
    55.9       78.9  
 
Other accrued expenses
    60.6       71.9  
 
 
   
     
 
   
Total current liabilities
    160.0       194.2  
Long-term debt
    175.0       170.5  
Deferred income taxes
    27.0       20.4  
Retained liabilities of previously owned businesses
    42.9       41.3  
Environmental liabilities
    33.9       35.0  
Asbestos liability
    41.2       59.9  
Other liabilities
    52.5       46.5  
 
 
   
     
 
   
Total liabilities
    532.5       567.8  
 
 
   
     
 
Shareholders’ equity
               
 
Common stock — $.01 par value; 100,000,000 shares authorized; issued, 20,447,047 shares in 2003 and 20,416,302 shares in 2002
    0.2       0.2  
 
Additional paid-in capital
    406.4       406.9  
 
Retained earnings (accumulated deficit)
    9.8       (7.7 )
 
Accumulated other comprehensive loss
    (0.4 )     (10.3 )
 
Common stock held in treasury, at cost — 245,018 shares
    (1.6 )     (1.6 )
 
 
   
     
 
   
Total shareholders’ equity
    414.4       387.5  
 
 
   
     
 
   
Total liabilities and shareholders’ equity
  $ 946.9     $ 955.3  
 
 
   
     
 

See notes to condensed consolidated financial statements (unaudited).

3


 

ENPRO INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.   Overview, Basis of Presentation and New Accounting Pronouncements

          Overview

          EnPro Industries, Inc. (“EnPro” or the “Company”) is a leader in the design, development, manufacturing and marketing of well recognized, proprietary engineered industrial products that include sealing products, metal polymer bearings, air compressors and heavy-duty diesel and natural gas engines.

          On May 31, 2002, Goodrich Corporation (“Goodrich”) completed the tax-free spin-off of its Engineered Industrial Products (“EIP”) business to its shareholders (the “Distribution”). EnPro was incorporated in North Carolina in January 2002 in anticipation of the proposed Distribution. Prior to the Distribution, Coltec Industries Inc (“Coltec”) was a wholly owned subsidiary of Goodrich and owned the EIP business and an aerospace business (“Coltec Aerospace”). During May 2002, Coltec transferred to Goodrich, by way of a dividend, all of the assets, liabilities and operations of Coltec Aerospace.

          Upon the Distribution, Coltec became a wholly owned subsidiary of EnPro. The Distribution was effected through a tax-free distribution to Goodrich shareholders of all of the capital stock of EnPro. Each Goodrich shareholder received one share of EnPro common stock, as well as an associated EnPro preferred stock purchase right, for every five shares of Goodrich common stock owned.

          Basis of Presentation

          These financial statements present Coltec’s condensed consolidated results of operations and cash flows as it operated as a wholly owned subsidiary of Goodrich prior to the Distribution on May 31, 2002, including certain adjustments and allocations necessary for a fair presentation of the business, and EnPro’s condensed consolidated results of operations, cash flows and financial condition after the Distribution. As noted above, Coltec transferred Coltec Aerospace to Goodrich prior to the Distribution. The transfer of Coltec Aerospace to Goodrich represented the disposal of a segment under APB Opinion No. 30, “Reporting the Results of Operations – Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions” (“APB 30”). Accordingly, Coltec Aerospace was accounted for as a discontinued operation and its revenues, costs and expenses, and cash flows have been segregated in the Company’s condensed consolidated statements of operations and condensed consolidated statements of cash flows. Unless otherwise noted, disclosures herein pertain to the Company’s continuing operations. There are no operations shown as discontinued operations other than Coltec Aerospace.

          In April 2003, the Company paid a final post-closing cash settlement of $0.6 million to Goodrich. This amount was reflected as a reduction of additional paid-in capital in the accompanying condensed consolidated balance sheet as of June 30, 2003.

          All significant transactions between the Company’s operations have been eliminated.

          Certain prior year amounts have been reclassified to conform to the current year presentation.

          Management believes that the assumptions underlying the condensed consolidated financial statements are reasonable. However, the financial information in the accompanying condensed consolidated statement of operations and condensed consolidated statement of cash flows for the quarter

4


 

and six months ended June 30, 2002, does not necessarily include all of the expenses that would have been incurred by Coltec had it been a separate, stand-alone entity prior to the Distribution and may not necessarily reflect what Coltec’s results of operations and cash flows would have been had Coltec been a stand-alone entity prior to the Distribution.

          The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation have been included.

          New Accounting Pronouncements

          In January 2003, FASB Interpretation No. 46 (“FIN 46”), “Consolidation of Variable Interest Entities,” was issued. The interpretation provides guidance on consolidating variable interest entities and applies immediately to variable interests created or obtained after January 31, 2003. The guidelines of the interpretation will become applicable to us in our third quarter 2003 financial statements for variable interest entities acquired before February 1, 2003. The interpretation requires variable interest entities to be consolidated if the equity investment at risk is not sufficient to permit an entity to finance its activities without support from other parties or the equity investors lack certain specified characteristics. We are reviewing FIN 46 to determine its impact, if any, on future reporting periods.

          In May 2003, Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity” (“SFAS 150”), was issued. SFAS 150 establishes standards for classifying and measuring as liabilities certain financial instruments that embody obligations of the Company and have characteristics of both liabilities and equity. SFAS 150 must be applied immediately to instruments entered into or modified after May 31, 2003, and will become applicable to us in our third quarter 2003 financial statements for all other pre-existing instruments. Since the 5¼% Convertible Preferred Securities — Term Income Deferred Equity Securities (“TIDES”) are primarily convertible into Goodrich common stock, they are not within the scope of SFAS 150.

2.   Mark-to-Market Adjustment for Call Options

          In March 2002, the Company purchased call options on Goodrich common stock to provide protection against the risk that the cash required to finance conversion of the TIDES into Goodrich common stock could exceed the $150 million liquidation value of the TIDES. The call options are derivative instruments and are carried at fair value in the Company’s condensed consolidated balance sheets. Changes in fair value are reflected in income. During the quarter and six months ended June 30, 2003, the Company recorded a $1.0 million increase and a $0.2 million decline, respectively, in the fair value of these call options. The fair value of the call options declined by $5.1 million during the quarter and six months ended June 30, 2002, and a corresponding non-cash charge to earnings was recorded to reflect this decline in value.

3.   Other Expenses

          During the second quarter of 2002, the Company recorded pre-tax charges of a non-operating nature totaling $25.2 million. These charges consisted of two primary components.

          First, in connection with the Distribution, the Company conducted a review of its process for managing and estimating environmental liabilities. As a result of changes in the Company’s strategies

5


 

growing out of this review, and in light of recent developments at a number of environmental sites associated with previously divested businesses, the Company increased its environmental reserves by approximately $12 million to reflect an increase in the estimated costs to remediate these sites.

          Second, based on an adverse court ruling related to severance owed as a result of the closing of a plant in 1982, the Company increased the reserve for this case by approximately $11 million in the quarter ended June 30, 2002.

4.   Restructuring Costs

          The Company incurred $0.5 million of facility consolidation costs in the first six months of 2003. Restructuring reserves at June 30, 2003, as well as activity during the six months ended June 30, 2003, consisted of:

                                 
    Balance                   Balance
    December 31,                   June 30,
    2002   Provision   Payments   2003
   
 
 
 
    (in millions)
Personnel related costs
  $ 0.9     $     $ (0.3 )   $ 0.6  
Facility consolidation costs
    0.1       0.5       (0.6 )      
 
   
     
     
     
 
 
  $ 1.0     $ 0.5     $ (0.9 )   $ 0.6  
 
   
     
     
     
 

          As of December 31, 2002, approximately 60 employees from previously announced workforce reductions had yet to be terminated. Fifty-four of these employees were terminated in the six months ended June 30, 2003.

5.   Comprehensive Income

          Total comprehensive income consisted of the following:

                                 
    Quarters   Six Months
    Ended June 30,   Ended June 30,
   
 
    2003   2002   2003   2002
   
 
 
 
    (in millions)
Net income (loss)
  $ 11.4     $ (1.3 )   $ 17.5     $ (2.7 )
Unrealized translation adjustments
    7.2       4.7       9.4       3.1  
Net unrealized gains from cash flow hedges
    0.4             0.5        
 
   
     
     
     
 
Total comprehensive income
  $ 19.0     $ 3.4     $ 27.4     $ 0.4  
 
   
     
     
     
 

6


 

6.   Earnings Per Share

          The computation of basic and diluted earnings per share is as follows:

                   
      Quarter Ended   Six Months Ended
      June 30, 2003   June 30, 2003
     
 
      (in millions, except per share amounts)
Numerator (basic and diluted):
               
 
Net income
  $ 11.4     $ 17.5  
 
 
   
     
 
Denominator:
               
 
Weighted-average shares – basic
    20.2       20.2  
 
Employee stock options
    0.4       0.2  
 
 
   
     
 
 
Weighted-average shares — diluted
    20.6       20.4  
 
 
   
     
 
Earnings per share:
               
 
Basic
  $ 0.57     $ 0.87  
 
 
   
     
 
 
Diluted
  $ 0.56     $ 0.86  
 
 
   
     
 

          Basic and diluted earnings per share for the quarter and six months ended June 30, 2002 were computed based on net loss divided by the average common shares outstanding during the period of 20.2 million shares. As of June 30, 2002, there were no dilutive common stock equivalents that would have caused diluted earnings per share to differ from basic earnings per share.

7.   Stock-Based Compensation

          The Company accounts for stock options using the intrinsic value method. Required pro forma information regarding net income and earnings per share has been determined as if the Company had accounted for its employee stock options under the fair value method.

          For purposes of the required pro forma disclosures, the estimated fair value of the options is amortized to expense over the vesting period of the options. The Company’s pro forma information is as follows:

                   
      Quarter Ended   Six Months Ended
      June 30, 2003   June 30, 2003
     
 
      (in millions, except per share amounts)
Net income:
               
 
As reported
  $ 11.4     $ 17.5  
 
Stock-based employee compensation cost, net of tax
    (0.4 )     (0.7 )
 
 
   
     
 
 
Pro forma
  $ 11.0     $ 16.8  
 
 
   
     
 
Basic earnings per share:
               
 
As reported
  $ 0.57     $ 0.87  
 
 
   
     
 
 
Pro forma
  $ 0.55     $ 0.83  
 
 
   
     
 
Diluted earnings per share:
               
 
As reported
  $ 0.56     $ 0.86  
 
 
   
     
 
 
Pro forma
  $ 0.54     $ 0.82  
 
 
   
     
 

7


 

8.   Inventories

          Inventories consisted of the following:

                   
      As of   As of
      June 30,   December 31,
      2003   2002
     
 
      (in millions)
Finished products
  $ 47.4     $ 63.8  
Work in process
    42.4       41.0  
Raw materials and supplies
    13.5       11.5  
 
   
     
 
 
    103.3       116.3  
Reserve to reduce certain inventories to LIFO basis
    (14.1 )     (14.1 )
Progress payments and advances
    (28.9 )     (40.3 )
 
   
     
 
 
Total
  $ 60.3     $ 61.9  
 
   
     
 

9.   Goodwill and Other Intangible Assets

          During 2002, the Company completed its initial assessment of goodwill using the two-step approach described in Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets” (“SFAS 142”). Goodwill was tested for impairment by comparing the fair value of the reporting units to their carrying value, including goodwill. The fair value was determined based on the discounted present value of estimated future cash flows. Since the carrying value of the assets of certain reporting units in the sealing products segment exceeded their fair value, a comparison was then made between the implied fair value of the goodwill, as defined by SFAS 142, and the carrying value of the goodwill. Goodwill related to the sealing products segment was determined to be impaired and, as required by SFAS 142, was reduced by $23.4 million ($14.6 million, net of tax) to its implied fair value. The reduction was recorded as a cumulative effect of a change in accounting principle. As required by SFAS 142, results for the quarter ended March 31, 2002, were restated to reflect the cumulative effect of the adoption of this accounting principle. Goodwill was previously evaluated for impairment by comparing the entity level unamortized goodwill balance to projected undiscounted cash flows, which had not resulted in an indication of impairment.

          The changes in the net carrying value of goodwill by reportable segment for the six months ended June 30, 2003, are as follows:

                         
    Sealing   Engineered        
    Products   Products   Total
   
 
 
    (in millions)
Goodwill, net, as of December 31, 2002
  $ 37.1     $ 86.6     $ 123.7  
Acquisition
    0.6             0.6  
Post-acquisition adjustments
          0.9       0.9  
 
   
     
     
 
Goodwill, net, as of June 30, 2003
  $ 37.7     $ 87.5     $ 125.2  
 
   
     
     
 

8


 

          The gross carrying amount and accumulated amortization of identifiable intangible assets is as follows:

                                 
    As of June 30, 2003   As of December 31, 2002
   
 
    Gross           Gross        
    Carrying   Accumulated   Carrying   Accumulated
    Amount   Amortization   Amount   Amortization
   
 
 
 
    (in millions)
Customer relationships
  $ 26.8     $ 4.8     $ 26.7     $ 3.4  
Existing technology
    16.4       0.8       15.8       0.6  
Trademarks
    22.7       1.8       22.7       1.6  
Other
    4.0       2.3       3.7       2.0  
 
   
     
     
     
 
 
  $ 69.9     $ 9.7     $ 68.9     $ 7.6  
 
   
     
     
     
 

          The Company has approximately $14 million of trademarks with indefinite lives as of June 30, 2003, and December 31, 2002.

          Amortization expense for the six months ended June 30, 2003, was $2.1 million. Amortization expense for these intangible assets for 2003 through 2007 is estimated to be approximately $4 million per year.

10.   Long-Term Debt

          In April 2003, the Company executed a $4.7 million variable rate promissory note in connection with certain pre-retirement death benefits payable to the Company’s executive officers. The promissory note is collateralized by life insurance policies. The promissory note bears interest at LIBOR plus a margin of 1.75%, or 3.12% as of June 30, 2003, which is adjusted annually. The promissory note is payable at the earliest of termination of the policies, death of persons insured under the policies, or sixty days prior to the expiration of the policies.

11.   Business Segment Information

          The Company has two reportable segments. The sealing products segment manufactures sealing and PTFE products. The engineered products segment manufactures metal polymer bearings, air compressors and components, heavy-duty diesel and natural gas engines and specialized tooling. The Company’s reportable segments are managed separately based on differences in their products and services. In the third quarter of 2002, operating responsibility for a business in the sealing products segment was transferred to the engineered products segment. Historical segment information has been reclassified to conform to this internal organization change. Segment profit is total segment revenue reduced by operating expenses and restructuring costs identifiable with the segment. Corporate expenses include general corporate administrative costs. The Company does not include income taxes or interest expense – net in the determination of segment profit. The accounting policies of the reportable segments are the same as those for the Company.

9


 

                                     
        Quarters Ended   Six Months
        June 30,   Ended June 30,
       
 
        2003   2002   2003   2002
       
 
 
 
                (in millions)        
Sales
                               
 
Sealing Products
  $ 86.2     $ 83.6     $ 168.3     $ 160.5  
 
Engineered Products
    112.5       108.1       214.8       199.0  
 
 
   
     
     
     
 
 
    198.7       191.7       383.1       359.5  
 
Intersegment sales
    (0.4 )     (0.5 )     (0.8 )     (1.0 )
 
 
   
     
     
     
 
   
Total sales
  $ 198.3     $ 191.2     $ 382.3     $ 358.5  
 
 
   
     
     
     
 
Segment Profit
                               
 
Sealing Products
  $ 14.8     $ 10.2     $ 25.6     $ 18.6  
 
Engineered Products
    10.5       11.4       21.6       20.4  
 
 
   
     
     
     
 
   
Total segment profit
    25.3       21.6       47.2       39.0  
Corporate expenses
    (5.5 )     (5.0 )     (10.9 )     (7.2 )
Asbestos-related expenses
    (2.5 )     (1.8 )     (5.4 )     (7.0 )
Interest – net
    (2.0 )     (3.2 )     (3.9 )     (9.8 )
Mark-to-market adjustment for call options
    1.0       (5.1 )     (0.2 )     (5.1 )
Other income (expenses)
    1.1       (25.8 )     0.1       (26.3 )
 
 
   
     
     
     
 
 
Income (loss) before income taxes and distributions on TIDES
  $ 17.4     $ (19.3 )   $ 26.9     $ (16.4 )
 
 
   
     
     
     
 

12.   Discontinued Operations

          Prior to the Distribution, Coltec transferred Coltec Aerospace to Goodrich by way of a dividend. The transfer of Coltec Aerospace to Goodrich represented the disposal of a segment under APB 30. Accordingly, Coltec Aerospace has been accounted for as a discontinued operation and its revenues, costs and expenses, and cash flows have been segregated in the Company’s condensed consolidated statements of operations and condensed consolidated statements of cash flows.

          The following summarizes the results of discontinued operations for the quarter and six months ended June 30, 2002, which consist solely of the results of Coltec Aerospace:

                 
    Quarter Ended   Six Months Ended
    June 30, 2002   June 30, 2002
   
 
    (in millions)
Sales
  $ 111.3     $ 292.9  
 
   
     
 
Pretax income
  $ 14.0     $ 36.1  
Income tax expense
    3.2       11.9  
 
   
     
 
Income from discontinued operations
  $ 10.8     $ 24.2  
 
   
     
 

10


 

13.   Commitments and Contingencies

          General

          There are pending or threatened against the Company or its subsidiaries various claims, lawsuits and administrative proceedings, all arising in the ordinary course of business with respect to commercial, product liability, asbestos and environmental matters, which seek remedies or damages. The Company believes that any liability that may finally be determined with respect to commercial and non-asbestos product liability claims should not have a material effect on the Company’s consolidated financial condition or results of operations. From time to time, the Company and its subsidiaries are also involved as plaintiffs in legal proceedings involving contract, patent protection, environmental and other matters. Gain contingencies, if any, are recognized when they are realized.

          Environmental

          The Company and its subsidiaries are generators of both hazardous wastes and non-hazardous wastes, the treatment, storage, transportation and disposal of which are subject to various laws and governmental regulations. Although past operations were in substantial compliance with the then applicable regulations, the Company has been designated as a potentially responsible party (“PRP”) by the U.S. Environmental Protection Agency, or similar state agencies, in connection with several sites.

          The Company initiates corrective and/or preventive environmental projects of its own to ensure safe and lawful activities at its current operations. It also conducts a compliance and management systems audit program. The Company believes that compliance with current laws and governmental regulations concerning the environment will not have a material adverse effect on its capital expenditures or results of operations.

          The Company’s environmental engineers and consultants review and monitor environmental issues at past and existing operating sites, as well as off-site disposal sites at which the Company has been identified as a PRP. This process includes investigation and remedial selection and implementation, as well as negotiations with other PRPs and governmental agencies.

          As of June 30, 2003, and December 31, 2002, the Company had an accrued liability of $35.9 million and $37.2 million, respectively, for probable future expenditures relating to environmental sites. The amounts recorded in the condensed consolidated financial statements have been recorded on an undiscounted basis. The Company believes that its reserves are adequate based on currently available information. Management believes that it is reasonably possible that additional costs may be incurred beyond the amounts accrued as a result of new information that may become available in the future. However, the amounts, if any, cannot be estimated and management believes that they would not be material to the Company’s consolidated financial condition, but could be material to the Company’s consolidated results of operations and cash flows in a given period.

          Colt Firearms and Central Moloney

          The Company has contingent liabilities related to divested businesses for which certain of its subsidiaries retained liability or are obligated under indemnity agreements. These contingent liabilities include, but are not limited to, potential product liability and associated claims related to the Company’s former Colt Firearms subsidiary for firearms manufactured prior to its divestiture in 1990 and the Company’s former Central Moloney subsidiary for electrical transformers manufactured prior to its divestiture in 1994. No material product liability claims are currently pending against the Company related to Central Moloney or Colt Firearms. Colt Firearms has been named as a defendant in approximately 30 cases filed by municipalities seeking to recover costs arising from gun related injuries.

11


 

Many of these cases have been dismissed or are inactive. Colt Firearms is seeking indemnification from Coltec for the remaining claims involving firearms manufactured prior to March 1990. The Company has rejected Colt Firearms’ claims for indemnification relating to the municipal gun cases in all instances on various legal grounds.

          The Company also has ongoing obligations, which are included in retained liabilities of previously owned businesses in the condensed consolidated balance sheets, with regard to workers’ compensation, retiree medical and other retiree benefit matters that relate to the Company’s periods of ownership of these operations.

          Crucible Materials Corporation

          The Company, through its Coltec subsidiary, owns 44% of the outstanding common stock of Crucible Materials Corporation (“Crucible”) through an irrevocable non-voting trust (the “Ownership Trust”). Crucible, which is engaged primarily in the manufacture and distribution of high technology specialty metal products, was a wholly owned subsidiary of Coltec until 1985. The Ownership Trust expires in May 2004, at which time Coltec will own the Crucible stock directly. Under the terms of the Ownership Trust, Coltec has not participated in the management of Crucible’s affairs and the Company has exercised no influence over the ongoing activities and business strategies of Crucible.

          Based on an evaluation of the recoverability of its investment in Crucible’s common stock, the investment is valued at zero in the Company’s condensed consolidated balance sheets. In addition, due to the lack of any oversight of Crucible’s activities, and due to the uncertainty surrounding the future recoverability of its investment in Crucible, the Company does not include its proportionate share of Crucible’s net income (loss) in its results of operations.

          A portion of the remaining 56% of the shares of Crucible are owned by Crucible-sponsored pension and profit sharing plans and the Crucible Employee Stock Ownership Plan (“ESOP”). As Crucible’s employees retire, they are entitled to redeem those shares and be paid the fair value of the shares by Crucible. In addition, provided certain conditions are met, Crucible’s pension plans have the right to sell their shares of Crucible common stock to Crucible. When shares are purchased by Crucible, the shares are retired and Coltec’s percentage ownership in Crucible increases.

          If Coltec’s percentage ownership of Crucible’s common stock were ever to exceed 50%, it may be deemed to be a “controlling person” with respect to the Crucible pension funds. As such, Coltec could be subject to certain liabilities with respect to Crucible’s pension obligations. If Crucible’s pension plans were to be terminated and the plans’ assets were not sufficient to cover the plans’ liabilities, Crucible and all members of its “controlled group” would be responsible for the unfunded termination liability. To the extent that Crucible could not fund any shortfall, Coltec could become responsible for funding the shortfall.

          The combined fair value of the assets in Crucible’s pension plans were approximately $20 million less than the accumulated benefit obligations at December 31, 2002. This amount is subject to change as the market value of the assets and interest rates fluctuate, as employees’ benefits change based on either plan amendments or additional credited service, and if contributions are made to the plans. In addition, in the event of a plan termination, the calculation of the actual termination liability would be based on more conservative interest rate assumptions and the deficit would likely be higher than the amount reflected above.

12


 

          Coltec’s ownership of Crucible’s common stock may never exceed 50% and Coltec may never become part of a “controlled group.” In addition, Crucible’s pension plans may never be terminated and Coltec may never bear any liability for any unfunded termination liability.

          In conjunction with the closure of a Crucible plant in the early 1980s, Coltec was required to fund two irrevocable trusts for retiree medical benefits for union employees at the plant. The first trust (the “Benefits Trust”) pays for these retiree medical benefits on an ongoing basis. Coltec has no continuing connection to the Benefits Trust, and thus the assets and liabilities of this trust are not included in the Company’s condensed consolidated balance sheets. Under the terms of the trust agreement, the trustees retained an actuary to assess the adequacy of the assets in the Benefits Trust in 1995, and other actuary reports will be required in 2005 and 2015. No contributions were required as a result of the valuation in 1995. If, at either or both of the future valuation dates, it is determined that the trust assets are not adequate to fund the payment of the medical benefits, Coltec will be required to contribute additional amounts. Based on preliminary information, an additional contribution might not be required in 2005. In the event there are ever excess assets in the Benefits Trust, those excess assets will not revert to Coltec.

          Because of the possibility of future contributions to the Benefits Trust, Coltec was required to establish a second trust (the “Back-Up Trust”) to cover potential shortfalls in the Benefits Trust. The assets and liabilities of the Back-Up Trust are reflected on the Company’s condensed consolidated balance sheets in other non-current assets and in retained liabilities of previously owned businesses, respectively, and amounted to $26.1 million each at June 30, 2003. If at the Benefits Trust review dates the actuary determines that there are excess assets in the Back-Up Trust, the excess assets will revert to Coltec based on a distribution formula and will be recorded in income upon receipt.

          The Company also has ongoing obligations, which are included in retained liabilities of previously owned businesses in the condensed consolidated balance sheets, with regard to workers’ compensation, retiree medical and other retiree benefit matters, in addition to those mentioned previously, that relate to the Company’s periods of ownership of these operations.

          Debt and Capital Lease Guarantees

          As of June 30, 2003, the Company had contingent liabilities for potential payments on guarantees of certain debt and lease obligations totaling $11.1 million. These guarantees arose from the divestiture of Crucible and Central Moloney and expire at various dates through 2010. There is no liability for these guarantees reflected in the Company’s condensed consolidated balance sheets. In the event that Crucible and Central Moloney do not fulfill their obligations under the debt and lease agreements, the Company could be responsible for these obligations.

          Product Warranties

          The Company provides warranties on many of its products. The specific terms and conditions of these warranties vary depending on the product and the market in which the product is sold. The Company records a liability based upon estimates of the costs that may be incurred under its warranties after a review of historical warranty experience and information about specific warranty claims. Adjustments are made to the liability as claim data and historical experience warrant.

13


 

          Changes in the carrying amount of the product warranty liability for the six months ended June 30, 2003, are as follows:

         
(In millions)        
Balance as of December 31, 2002
  $ 5.7  
Warranties issued
    2.1  
Settlements made
    (2.2 )
 
   
 
Balance as of June 30, 2003
  $ 5.6  
 
   
 

          Asbestos

          History. Certain of the Company’s subsidiaries, primarily Garlock Sealing Technologies, LLC (“Garlock”) and The Anchor Packing Company (“Anchor”), are among a number of defendants (typically 15 to 40 and sometimes more than 100) in actions filed in various states by plaintiffs alleging injury or death as a result of exposure to asbestos fibers. Except for claims against Garlock and Anchor, the number of claims to date has not been significant. Among the products at issue in these actions are industrial sealing products, predominantly gaskets and packing products, manufactured and/or sold by Garlock or Anchor. The damages claimed vary from action to action and in some cases plaintiffs seek both compensatory and punitive damages. To date, neither Garlock nor Anchor has been required to pay any punitive damage awards, although there can be no assurance that they will not be required to do so in the future. Liability for compensatory damages has historically been allocated among all responsible defendants, thus limiting the potential monetary impact of a particular judgment or settlement on any individual defendant. Since the first asbestos-related lawsuits were filed against Garlock in 1975, Garlock and Anchor have processed approximately 500,000 asbestos claims to conclusion (including judgments, settlements and dismissals) and, together with their insurers, have paid approximately $877 million in settlements and judgments at a cost in fees and expenses of an additional $283 million.

          Claims Mix. Of those claims resolved, approximately 2% have been claims of plaintiffs alleging the disease mesothelioma, approximately 6% have been claims of plaintiffs with lung or other cancers, and approximately 92% have been claims of plaintiffs alleging asbestosis, pleural plaques or other impairment of the respiratory system of varying degree. Because the more serious disease cases tend to work through the system more quickly than the non-malignancy cases and the cases filed by those who are not impaired, the Company believes that the disease mix in our current open caseload, on a percentage basis, is even more skewed toward pleural plaques and includes a large number of claims made by plaintiffs who have suffered no disease and have no measurable impairment of any kind. In fact, while there are many cases in our current open caseload about which we have no disease information, we are aware of only approximately 7,000 that involve a claimant with mesothelioma, lung cancer or some other cancer.

          Product Defenses. The Company believes that Garlock and Anchor are in a favorable position compared to many other asbestos defendants because, among other things, the asbestos-containing products formerly sold by Garlock and Anchor were encapsulated, which means the asbestos fibers were incorporated into the product during the manufacturing process and sealed in a binder. They are also nonfriable, which means they cannot be crumbled by hand pressure. The Occupational Safety and Health Administration, which began generally requiring warnings on asbestos-containing products in 1972, has never required that a warning be placed on products such as Garlock’s gaskets. Notwithstanding that no warning label has been required, Garlock included one on all of its asbestos-containing products beginning in 1978. Further, gaskets such as those previously manufactured and sold by Garlock are one of the few asbestos-containing products still permitted to be manufactured under regulations of the Environmental Protection Agency. Since the mid-1980s, U.S. sales of asbestos-containing industrial sealing products have not been a material part of Garlock’s sales and sales of asbestos-containing

14


 

products have been predominantly to sophisticated purchasers such as the U.S. Navy and large petrochemical facilities. These purchasers generally have extensive health and safety procedures and are familiar with the risks associated with the use and handling of industrial sealing products that contain asbestos. Garlock discontinued distributing asbestos-containing products in the U.S. during 2000 and worldwide in mid-2001.

          Since the beginning of 2003, Garlock’s product defenses enabled it to win defense verdicts in all three cases that it tried to verdict. Those trials were in California, Kentucky and Texas. In all three cases, the jury determined that Garlock’s products were not defective and that Garlock was not negligent.

          Settlements. Garlock settles and disposes of actions on a regular basis. In addition, some actions are disposed of at trial. Garlock’s historical settlement strategy has been to try to match the timing of payments with recoveries received from insurance, which, as described later, were limited to $80 million per year through the second quarter of 2003. However, in 1999 and 2000, Garlock implemented a short-term aggressive settlement strategy. The purpose of this short-term strategy was to achieve a permanent reduction in the number of overall asbestos claims through the settlement of a larger than normal number of claims, including some claims not yet filed as lawsuits. Mainly due to this short-term aggressive settlement strategy, but also because of a significant overall increase in claims filings, the settlement amounts paid in each of the years 1999 through 2002 were greater than the amounts paid in any year prior to 1999. In 2001, Garlock resumed its historical settlement strategy. In fact, Garlock reduced new settlement commitments from $180 million in 2000, to $94 million in 2001, and to $86 million in 2002. However, because of commitments made in 1999 and 2000 that will be paid over a number of years, the settlement amounts that Garlock will pay in 2003 through 2005 will continue to include amounts for settlements made during 1999, 2000 and early 2001.

          Settlements are made without any admission of liability and are generally made on a group basis with payments made to individual claimants over a period of one to four years. Settlement amounts vary depending upon a number of factors, including the jurisdiction where the action was brought, the nature and extent of the disease alleged and the associated medical evidence, the age and occupation of the plaintiff, the presence or absence of other possible causes of the plaintiff’s alleged illness, the availability of legal defenses, and whether the action is an individual one or part of a group. Garlock believes that its allocable portion of the total settlement amount for an action has typically ranged from 1% to 2% of the total amount paid by all defendants in the action.

          Before any payment on a settled claim is made, the claimant is required to submit a medical report acceptable to Garlock substantiating the asbestos-related illness and meeting specific criteria of disability. In addition, sworn testimony or other evidence that the claimant worked with or around Garlock asbestos-containing products is required. The claimant is also required to sign a full and unconditional release of Garlock, its subsidiaries, parent, officers, directors, affiliates and related parties from any liability for asbestos-related injuries or claims.

          When a settlement demand is not reasonable given the totality of the circumstances, Garlock generally will try the case. Garlock has been successful in winning a substantial majority of the cases it has tried to verdict. Garlock’s share of adverse verdicts in these cases in the years 2000 through 2002 totaled approximately $6 million in the aggregate, and some of those verdicts are on appeal. As previously reported, Garlock won defense verdicts in all three cases it tried to verdict in the first six months of 2003.

          Status of Anchor. Anchor is an inactive and insolvent indirect subsidiary of Coltec. The insurance coverage available to Anchor of approximately $9 million as of June 30, 2003, is fully committed. Anchor continues to pay settlement amounts covered by its insurance but has not committed

15


 

to settle any further actions since 1998. As cases reach the trial stage, Anchor is typically dismissed without payment.

          Insurance Coverage. The insurance coverage available to Garlock is substantial. As of June 30, 2003, Garlock had available $851 million of insurance coverage from carriers that it believes to be solvent. Garlock classifies $70 million of otherwise available insurance as insolvent. The Company believes Garlock will recover some of the insolvent insurance over time. In fact, Garlock recovered $2 million from an insolvent carrier during the year ended December 31, 2002, and $1.9 million during the first six months of 2003. Of the solvent insurance, $661 million (78%) is with US-based carriers whose credit rating by S&P is investment grade (BBB) or better, and whose AM Best rating is excellent (A-) or better, $63 million (7%) is with other solvent US carriers and $127 million (15%) is with various solvent London market carriers. Of the $851 million, $169 million is allocated to claims that have been paid by Garlock and submitted to its insurance companies for reimbursement and $94 million has been committed to claim settlements not yet paid by Garlock. Thus, at June 30, 2003, $588 million remained available for future asbestos-related settlements.

          Arrangements with Garlock’s insurance carriers limit the amount that can be received by it in any one year. The amount of insurance available to cover asbestos-related payments by Garlock was limited to $80 million per year through the second quarter of 2003. This limit automatically increases by 8% every three years. The next scheduled increase will impact recoveries beginning in the third quarter of 2003. Amounts paid by Garlock in excess of this annual limit that would otherwise be recoverable from insurance may be collected from the insurance companies in subsequent years so long as insurance is available, subject to the annual limit available in each subsequent year. As a result, Garlock is required to pay out of its own cash any amounts paid to settle or dispose of asbestos-related claims in excess of the annual limit and collect these amounts from its insurance carriers in subsequent years. To the extent that Garlock pays such amounts in a given year, these payments are recorded as a receivable. The amounts paid in excess of insurance recoveries thus far in 2003 that were recorded as a receivable amounted to $18.1 million. Garlock is pursuing various options, such as raising the annual limit and commuting policies at discounted values, to ensure as close a match as possible between payments by Garlock and recoveries received from insurance carriers. There can be no assurance that Garlock will be successful as to any or all of these options.

          Insurance coverage for asbestos claims is not available to cover exposures initially occurring on and after July 1, 1984. Garlock and Anchor continue to be named as defendants in new actions, a few of which allege initial exposure after July 1, 1984. To date, no payments have been made with respect to these claims, pursuant to a settlement or otherwise. In addition, Garlock and Anchor believe that they have substantial defenses to these claims and therefore automatically reject them for settlement. However, there can be no assurance that any or all of these defenses will be successful in the future.

          Quantitative Claims Information. In accordance with internal procedures for the processing of asbestos product liability actions and due to the proximity to trial or settlement, certain outstanding actions against Garlock have progressed to a stage where the Company believes it can reasonably estimate the cost to dispose of these actions. These actions are classified as actions in advanced stages and the estimated costs to dispose of them are included in the table below. With respect to outstanding actions against Garlock that are in preliminary procedural stages, as well as any actions that may be filed in the future, the Company believes that insufficient information exists upon which judgments can be made as to the validity or ultimate disposition of such actions. Therefore, the Company believes that it is impossible to estimate with any degree of accuracy or reasonableness what, if any, potential liability or costs may be incurred. Accordingly, the Company has not included any estimate of future liability for such claims in the table below.

16


 

          The Company records an accrual for liabilities related to Garlock and Anchor asbestos-related matters that are deemed probable and can be reasonably estimated, which consist of settled claims and actions in advanced stages of processing. The Company also records an asset for the amount of those liabilities that it expects Garlock and Anchor to recover from insurance. A table is provided below depicting quantitatively the items discussed above.

                   
      As of and for the
      Six Months Ended
      June 30,
     
      2003   2002
     
 
(number of cases)
               
 
New Actions Filed During the Period (1)
    33,900       16,200  
 
Open Actions at Period-End (1)
    139,900       102,900  
(dollars in millions at period-end)
               
 
Estimated Amounts Recoverable from Insurance (2)
  $ 272.3     $ 347.0  
 
Estimated Liability for Settled Claims and Actions in Advanced Stages of Processing (3)
  $ 97.1     $ 181.3  
(dollars in millions)
               
 
Payments (4)
  $ 73.6     $ 80.4  
 
Insurance Recoveries (4)
    50.1       30.5  
 
 
   
     
 
 
Net Cash Flow
  $ (23.5 )   $ (49.9 )
 
 
   
     
 

(1)   Consists only of actions actually filed with a court of competent jurisdiction. To the extent that a particular action names both Garlock and Anchor as defendants, for purposes of this table, the action is treated as a single action.
 
(2)   At June 30, 2003, included $175.2 million representing cumulative payments made for which Garlock has not received a corresponding insurance recovery due to the annual limit imposed under Garlock’s insurance policies, and which will be recovered in future periods to the extent insurance is available. Also included at June 30, 2003, is $97.1 million representing amounts recoverable under insurance policies related to the estimated liability for settled claims and actions in advanced stages of processing. At June 30, 2003, $88.1 million was classified as a current asset and $184.2 million was classified as a non-current asset in the condensed consolidated balance sheets.
 
(3)   Includes amounts with respect to all claims committed in the period, whether or not an action has actually been filed with a court of competent jurisdiction. At June 30, 2003, $55.9 million was classified as a current liability and $41.2 million was classified as a non-current liability in the condensed consolidated balance sheets.
 
(4)   Includes amounts with respect to all payments for claims settlements and expenses and recoveries made in the period. In the six months ended June 30, 2003 and 2002, $18.1 million and $43.0 million, respectively, of the net cash flows were added to the asbestos insurance receivable in the condensed consolidated balance sheets, and $5.4 million and $7.0 million, respectively, was recorded as an expense in the condensed consolidated statements of operations.

          Considering the foregoing, as well as the experience of Coltec’s subsidiaries and other defendants in asbestos litigation, the likely sharing of judgments among multiple responsible defendants, recent bankruptcies of other defendants, and legislative efforts, and given the substantial amount of insurance coverage that Garlock expects to be available from its solvent carriers, the Company believes that pending actions against Garlock and Anchor are not likely to have a material adverse effect on its financial condition, but could be material to its results of operations or cash flows in a given period. The Company

17


 

anticipates that asbestos-related actions will continue to be filed against Garlock. Because of the uncertainty as to the number and timing of potential future actions, as well as the amount that will have to be paid to settle or satisfy any such actions in the future, there can be no assurance that those future actions will not have a material adverse effect on the Company’s financial condition, results of operations and cash flows.

18


 

PART I, ITEM 2.

ENPRO INDUSTRIES, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS

          The following is management’s discussion and analysis of certain significant factors that have affected our financial condition, cash flows and operating results during the periods included in the accompanying unaudited condensed consolidated financial statements and the related notes. You should read this in conjunction with those financial statements and the audited consolidated financial statements and related notes included in our annual report on Form 10-K for the fiscal year ended December 31, 2002.

Overview

          EnPro Industries, Inc. (“EnPro” or the “Company”) was incorporated on January 11, 2002, as a wholly owned subsidiary of the Goodrich Corporation (“Goodrich”) in anticipation of Goodrich’s announced distribution of its Engineered Industrial Products (“EIP”) segment to existing Goodrich shareholders, which took place on May 31, 2002 (the “Distribution”). We are leaders in the design, development, manufacturing and marketing of well recognized, proprietary engineered industrial products that include sealing products; self-lubricating, non-rolling, metal polymer bearing products; air compressor systems and vacuum pumps; and heavy-duty diesel and natural gas engines. We also design, manufacture and sell other engineered industrial products such as PTFE products and specialized tooling.

          We manage our business as two segments, a sealing products segment (sealing and PTFE products) and an engineered products segment (metal polymer bearings, air compressor systems and components, heavy-duty diesel and natural gas engines and specialized tooling). In 2002, we transferred operating responsibility for a business in the sealing products segment to the engineered products segment. Historical segment information has been reclassified to conform to this internal organization change. Segment profit is total segment revenue reduced by operating expenses and restructuring costs identifiable with the segment. The accounting policies of the reportable segments are the same as those for EnPro.

          The following discusses Coltec Industries Inc’s (“Coltec”) condensed consolidated results of operations, cash flows and financial condition as it operated as a wholly owned subsidiary of Goodrich prior to the Distribution on May 31, 2002, including the adjustments and allocations necessary for a fair presentation of the business, and EnPro’s condensed consolidated results of operations, cash flows and financial condition after the Distribution. Prior to the Distribution, Coltec owned the EIP business as well as an aerospace business. The transfer of Coltec’s aerospace business to Goodrich prior to the Distribution represented the disposal of a segment under APB 30. Accordingly, Coltec’s aerospace business was accounted for as a discontinued operation and its revenues, costs and expenses and cash flows have been segregated in the historical condensed consolidated financial statements. Unless otherwise noted, the following discussion pertains only to continuing operations. Following the Distribution, Coltec is a wholly owned subsidiary of EnPro and Coltec’s aerospace business is owned by Goodrich.

          The following discussion of the condensed consolidated results of operations does not necessarily include all of the expenses that would have been incurred by Coltec prior to the Distribution had it been a separate, stand-alone entity and may not necessarily reflect what Coltec’s condensed consolidated results

19


 

of operations and cash flows would have been had Coltec been a stand-alone entity prior to the Distribution or what our condensed consolidated results of operations and cash flows may be in the future.

Results of Operations – Second Quarter of 2003 Compared to the Second Quarter of 2002

          Sales of $198.3 million in the second quarter of 2003 were 4% higher than the $191.2 million reported in the comparable quarter of 2002. Sales benefited mainly from favorable foreign currency exchange rates and increased sales activity at Stemco. The average U.S. dollar-euro exchange rate during the second quarter of 2003 increased 24% from the same quarter last year. This change favorably impacted revenue principally at the European operations of Garlock Sealing Technologies, Glacier Garlock Bearings (“GGB”) and France Compressor Products. Without the benefit of the stronger foreign currency exchange rates, sales would have declined by about 1%. The decline was primarily due to flat or lower sales at all units, except Stemco, caused by lower volumes and pricing pressure. Our sales and order activity continue to be negatively impacted by weak U.S. industrial markets and historically low capacity utilization levels. Similarly weak activity in Europe was evident during the current quarter as well.

          Segment profit increased 17% from $21.6 million in the second quarter of 2002 to $25.3 million in the second quarter of 2003. Stronger foreign currency exchange rates, reduced restructuring costs and positive developments that resulted in reductions of liabilities for warranty and legal matters accounted for the quarter-over-quarter increase in segment profit. In addition, the second quarter of 2002 includes the effect of a charge for a warranty claim. These increases were partially offset by lower sales volumes, pricing pressures and a less profitable product mix. Segment margins increased from 11.3% to 12.8% in the second quarter of 2002 and 2003, respectively.

          Income from continuing operations and net income in the second quarter of 2003 was $11.4 million, or $0.56 per share. This compares to a loss from continuing operations of $12.1 million, or $0.60 per share, and a net loss of $1.3 million, or $0.06 per share, in the second quarter of 2002. Earnings per share are expressed on a diluted basis throughout “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Besides segment profit discussed above, other significant factors that impacted income (loss) from continuing operations and net income (loss) are discussed below.

          Interest expense - net decreased to $2.0 million in the second quarter of 2003 from $3.2 million in the comparable quarter last year mainly due to the reduction in the Coltec 7½% senior notes. All but $3.1 million of the original principal amount of these notes were exchanged prior to the Distribution for similar Goodrich debt securities, which were retained by Goodrich.

          Results of operations in the second quarter of 2003 include a $1.0 million increase in the fair value of our call options on Goodrich common stock. Conversely, the second quarter of 2002 included a $5.1 million charge for a decline in the fair value of these call options. We purchased the call options as protection against the risks associated with the 5¼% Convertible Preferred Securities – Term Income Deferred Equity Securities (“TIDES”) included in our long-term debt, which are convertible into Goodrich common stock. The call options are derivative instruments and are carried at fair value with changes in the fair value reflected in income. Changes in the fair value of the call options do not impact cash flows.

          During the second quarter of 2002, we recorded pre-tax charges of a non-operating nature in other income (expenses) totaling $25.2 million, or $15.8 million after tax. These charges consisted of two primary components. First, in connection with the Distribution, we conducted a review of our process for managing and estimating environmental liabilities. As a result of changes in our strategies growing out of this review, and in light of recent developments at a number of environmental sites associated with

20


 

previously divested businesses, we increased our environmental reserves by approximately $12 million to reflect an increase in the estimated costs to remediate those sites. Second, based on an adverse court ruling related to severance owed as a result of the closing of a plant in 1982, we increased the reserve for this case by approximately $11 million in the second quarter of 2002.

          The effective tax rate changed from a benefit of 44.0% on the pre-tax loss in the prior year to an expense of 34.1% in the second quarter of 2003. In 2003, we received a tax refund from prior years related to a previously owned business and have made adjustments for pre-Distribution items that have favorably impacted the effective tax rate and will continue to do so throughout this year. As a result of the pre-tax loss in the second quarter of 2002, the tax benefit associated with the TIDES distributions increased the effective rate during that period.

Following is a discussion of operating results for each segment:

          Sealing Products - Sales of $86.2 million in the second quarter of 2003 were 3% higher than the $83.6 million reported in the same period in 2002. Without the positive effect of the U.S. dollar-euro exchange rate change, sales would have declined by 1%. Sales at Garlock Sealing Technologies were down 4%, after excluding the positive effects of the U.S. dollar-euro exchange rates, due to volume declines in several product lines and competitive pricing pressures. Stemco sales were bolstered by a modest increase in aftermarket order levels and a significant increase in OEM orders from manufacturers of heavy-duty vehicles as that market continues to rebound from the decline that began in late 1999. Garlock Rubber Technologies’ sales were down 5% in what continue to be very competitive markets for its products. Demand for Plastomer Technologies’ PTFE products was negatively impacted by weakness in the aerospace, semiconductor and chemicals markets.

          Segment profit increased 45% from $10.2 million in the second quarter of 2002 to $14.8 million in the same period this year. Excluding the impact of the favorable U.S. dollar-euro exchange rate, segment profit would have increased by 35%. Garlock Sealing Technologies benefited from the foreign currency exchange rates and cost reductions, which were partially offset by the volume declines and pricing pressures. In addition, this unit recorded a charge for a warranty claim in the second quarter of 2002, which reduced segment profit. Increased volume and favorable pricing were the main contributors to increased profitability at Stemco. Garlock Sealing Technologies and Plastomer Technologies also reported improvements in segment profit resulting from lower restructuring costs. Operating margins increased from 12.2% in the second quarter of 2002 to 17.1% in the second quarter of 2003.

          Engineered Products - In the second quarter of 2003, sales were $112.5 million, a 4% increase over the $108.1 million reported in the same period last year. Excluding the favorable U.S. dollar-euro exchange rate change, sales would have declined by about 1%. Sales at Fairbanks Morse Engine, Haber/Sterling and France Compressor Products were essentially flat quarter-over-quarter, excluding the positive impact of stronger foreign currency exchange rates for France Compressor Products. Sales at GGB, also excluding the positive effect of stronger foreign currency exchange rates, were down slightly mainly due to soft demand in its European markets. Weak capital equipment demand continues to dampen order levels at Quincy Compressor.

          Segment profit declined by 8% from $11.4 million in the second quarter of 2002 to $10.5 million in the second quarter of 2003. Excluding the effect of the favorable U.S. dollar-euro exchange rate change, segment profit would have declined by 14%. GGB, without considering the favorable foreign currency exchange rates, and Quincy Compressor accounted for the decline. Fairbanks Morse Engine partially offset this mainly due to continued cost reductions and positive developments in a legal matter and warranty claims that led to the reversal of the reserves for these items. Segment profit at France Compressor Products and Haber/Sterling was essentially flat. Operating margins were 9.4% and 10.6% in the second quarter of 2003 and 2002, respectively.

21


 

Results of Operations – Six Months Ended June 30, 2003 Compared to the Six Months Ended June 30, 2002

          Sales for the six months ended June 30, 2003, increased 7%, from $358.5 million in the first six months of 2002 to $382.3 million in the first six months of 2003. A loss from continuing operations of $12.3 million, or $0.61 per share, in the first half of 2002 compares to net income of $17.5 million, or $0.86 per share, in the same period of 2003. After including the income from the discontinued Coltec aerospace business and the cumulative effect of the change in accounting principle for goodwill and other intangible assets, the net loss in the six months ended June 30, 2002, amounted to $2.7 million, or $0.14 per share. The factors affecting the results of operations for the first six months of 2003 and 2002 were substantially the same as those discussed for the second quarter, with the following exceptions.

          Asbestos-related expenses were $5.4 million in the first six months of 2003 compared to $7.0 million during the comparable period in 2002. The expenses in 2003 were lower primarily as a result of decreased spending on legal fees and expenses associated with managing and settling asbestos-related claims.

          The fair value of the call options on Goodrich common stock declined by $0.2 million and $5.1 million during the six months ended June 30, 2003 and 2002, respectively.

Non –GAAP Supplemental Financial Measures

Reconciliation of GAAP Net Income (Loss) to Non-GAAP “As Adjusted” Net Income (Unaudited)

          On May 31, 2002, Goodrich completed the tax-free Distribution of its EIP business to its shareholders. Prior to the Distribution, Coltec, which at that time was a Goodrich subsidiary, owned the EIP business and an aerospace business. During May 2002, Coltec transferred to Goodrich, by way of a dividend, all of the assets, liabilities and operations of the aerospace business. Upon the Distribution, Coltec became a wholly owned subsidiary of EnPro. The financial results prior to the Distribution include the results of the aerospace business and certain other assets and liabilities (and the associated income and expenses) that were retained by Goodrich and not distributed as part of the Distribution.

          To assist in understanding the performance of our operations, we present supplemental financial measures. The measures do not conform to U.S. generally accepted accounting principles, or GAAP. Earnings or losses as a result of these measures are referred to as “as adjusted.” While we believe that these measures are useful aids in understanding our results in the periods shown and we use these measures internally to evaluate our performance, they should be used only in conjunction with results presented in accordance with GAAP. A table reconciling the “as adjusted” results with the most comparable GAAP measurement follows.

          In addition, while a part of Goodrich, Coltec was allocated a portion of certain corporate administrative expenses. These expenses were not representative of the level that would have been incurred had Coltec operated as an independent public company during that period.

          During the second quarter of 2002, we recorded pre-tax charges of a non-operating nature totaling $25.2 million, or $15.8 million after tax. These charges consisted of two primary components. First, in connection with the Distribution, we conducted a review of our process for managing and estimating environmental liabilities. As a result of changes in the our strategies growing out of this review, and in light of recent developments at a number of environmental sites associated with previously divested businesses, we increased our environmental reserves by approximately $12 million to reflect an increase in the estimated costs to remediate those sites. Second, based on an adverse court ruling

22


 

related to severance owed as a result of the closing of a plant in 1982, we increased the reserve for this case by approximately $11 million in the quarter ended June 30, 2002.

          In March 2002, we purchased call options on Goodrich common stock to provide protection against the risk that the cash required to finance conversion of the TIDES into Goodrich common stock would exceed the liquidation value of the TIDES. The call options are a derivative instrument and are carried at fair value on our balance sheets. Changes in fair value are reflected in income. During the quarter and six months ended June 30, 2003, we recorded a $1.0 million increase and a $0.2 million decline, respectively, in the fair value of these call options. During the quarter and six months ended June 30, 2002, we recorded a $5.1 million decline in the fair value of these call options.

          With respect to the amounts described above, we believe that:

  1.   the magnitude of the items is such that it is important for readers of our condensed consolidated financial statements to be aware of these items and the effect that they had on net income (loss) during the periods presented; and
 
  2.   with respect to the mark-to-market adjustment on our call options on Goodrich common stock, the expense we recognized does not involve an additional cash outlay and is driven by changes in the Goodrich stock price that have no bearing on our operating activities.

          Based on the factors cited above, we believe that it is helpful in understanding the ongoing operating results to provide non-GAAP supplemental financial measures showing the GAAP results adjusted to eliminate the impact of income and expenses associated with assets and liabilities retained by Goodrich that will have no bearing on our ongoing results in the future. In addition, we believe that the non-GAAP supplemental financial measures are more meaningful if the operating results are further adjusted to approximate what they would have been had we operated as an independent public company during all periods presented, and if we exclude from the GAAP results those items that are not representative of our ongoing operational activities. As a result, we have eliminated the items mentioned above as well as the income from discontinued operations and the cumulative effect of the change in accounting principle for goodwill and other intangible assets.

23


 

Non-GAAP Supplemental Financial Measures – As Adjusted (Unaudited)

For the Quarters and Six Months Ended June 30,
2003 and 2002 (Stated in Millions of Dollars)

                                     
        Quarters Ended June 30,   Six Months Ended June 30,
       
 
        2003   2002   2003   2002
       
 
 
 
GAAP net income (loss)
  $ 11.4     $ (1.3 )   $ 17.5     $ (2.7 )
Eliminate items included in GAAP results (net of tax):
                               
   
Mark-to-market adjustment for call options (1)
    0.7       3.2       0.1       3.2  
   
Other (income) expenses (2)
    (0.3 )     15.8       (0.3 )     15.8  
   
Income tax expense (3)
    (0.5 )           (0.7 )      
   
Results of discontinued operations
          (10.8 )           (24.2 )
   
Cumulative effect of a change in accounting principle
                      14.6  
   
Interest expense on debt retained by Goodrich (4)
          0.6             5.4  
Add items not included in GAAP results (net of tax):
                               
   
Corporate administrative costs (5)
          0.5             (0.8 )
 
   
     
     
     
 
 
Non-GAAP “as adjusted” net income
  $ 9.9     $ 8.0     $ 16.6     $ 11.3  
 
   
     
     
     
 
EPS – GAAP (basic)
  $ 0.57     $ (0.06 )   $ 0.87     $ (0.14 )
 
   
     
     
     
 
EPS – GAAP (diluted)
  $ 0.56     $ (0.06 )   $ 0.86     $ (0.14 )
 
   
     
     
     
 
EPS - - Non-GAAP "as adjusted" (basic)
  $ 0.49     $ 0.40   $ 0.82     $ 0.56
 
   
     
     
     
 
EPS - - Non-GAAP "as adjusted" (diluted)
  $ 0.48     $ 0.40   $ 0.81     $ 0.56
 
   
     
     
     
 

(1)   Represents the net of tax charge (credit) for the mark-to-market adjustments for the call options on Goodrich common stock.
 
(2)   Represents the net of tax impact of the non-operating amounts discussed previously.
 
(3)   Represents a reduction in the current year effective tax rate for a tax refund from prior years related to a previously owned business and other adjustments for pre-Distribution items.
 
(4)   Prior to the Distribution, Goodrich offered to exchange new Goodrich debt securities for the Coltec 7½% senior notes. Goodrich acquired $296.9 million of the Coltec 7½% senior notes tendered pursuant to the offer. The $3.1 million of Coltec 7½% senior notes that remained outstanding following completion of the exchange offer continue to be obligations of Coltec. An adjustment has been made in the quarter and six months ended June 30, 2002, to eliminate the interest expense, after tax, on the Coltec 7½% senior notes acquired by Goodrich.

24


 

(5)   Represents an adjustment to reflect management’s estimate of the corporate administrative costs that would have been incurred had we operated as an independent public company prior to the Distribution.

Liquidity and Capital Resources

          Cash Flows

          Operating activities provided $1.5 million of cash during the first six months of 2003 and used $19.2 million during the first six months of 2002. The cash provided in 2003, included payments for asbestos-related claims of $17.7 million, an increase in working capital of $14.6 million, and a contribution to two U.S. pension plans totaling $4.0 million. Working capital typically increases in the first half of the year as a result of increased activity, although the working capital increase in 2002 was less mainly due to the receipt of a tax refund early in the year. Net cash outflows for asbestos-related claims settlements and expenses, net of insurance proceeds, during the first six months of 2003 were $23.5 million compared to $49.9 million in the same period last year. Net cash flows for the first six months of 2002 were higher than the comparable amount in the first six months of 2003 partly due to the late receipt in 2002 of a scheduled insurance collection of approximately $15 million that was not received until July 2002. See “Contingencies – Asbestos” for additional discussion regarding asbestos-related matters.

          Investing activities used $7.5 million and $22.8 million of cash during the first six months of 2003 and 2002, respectively. In 2003, cash was used mainly for capital expenditures and to acquire a small product line that was added to the sealing products segment. In 2002, $16.2 million was used to purchase the call options on Goodrich common stock.

          Financing activities provided cash amounting to $4.1 million in the first six months of 2003 and $50.0 million during the same period last year. Prior to the Distribution, our cash disbursements and cash receipts were managed in a corporate cash concentration system. We describe this activity as net transfers (to) from Goodrich in the condensed consolidated statements of cash flows. Refer to “- Capital Resources” for information regarding the net addition to debt in 2003.

          Capital Resources

          In April 2003, we executed a $4.7 million variable rate promissory note in connection with certain pre-retirement death benefits payable to our executive officers. The promissory note is collateralized by life insurance policies. The promissory note bears interest at LIBOR plus a margin of 1.75%, or 3.12% as of June 30, 2003, which is adjusted annually. The promissory note is payable at the earliest of termination of the policies, death of persons insured under the policies, or sixty days prior to the expiration of the policies. This is the second of three borrowings with similar terms and conditions. The last borrowing is expected in April 2004.

          Our primary U.S. subsidiaries executed a credit agreement dated May 16, 2002, for a senior secured revolving credit facility. Borrowings under the senior secured revolving credit facility are collateralized by receivables, inventories, equipment, intellectual property, insurance receivables and all other personal property assets of EnPro and its U.S. subsidiaries and by a pledge of 65% of the capital stock of their direct foreign subsidiaries. The maximum available amount under the senior secured revolving credit facility is $60 million. The senior secured revolving credit facility contains customary restrictions, covenants and events of default for financings of this type, including without limitation, restrictions on our ability to pay dividends, the repurchase of shares, the incurrence of additional debt, and the acquisition of new businesses. We do not expect compliance with these restrictions and covenants to materially affect our operations. We have not borrowed against this credit facility.

25


 

          Coltec has outstanding $150 million of TIDES due April 15, 2028. The TIDES are convertible at a conversion price of $52.34 per TIDES, at the option of the holder, into a combination of 0.955248 of a share of Goodrich common stock and 0.1910496 of a share of EnPro common stock. Should the holders exercise their right to convert the TIDES, Coltec would be required to deliver shares of Goodrich and EnPro common stock to the holders as promptly as practicable after the conversion date and in connection therewith would be required to purchase shares of Goodrich common stock in the open market, directly from Goodrich or by exercising its call options on Goodrich common stock discussed below. Coltec may not have sufficient cash on hand or the ability to finance these transactions in the time period required by the TIDES agreements. Failure to honor conversion rights would be a default under those agreements.

          Further, the value of Goodrich and EnPro common stock may increase to a level where Coltec’s cost to acquire shares in a conversion could exceed, with no maximum, the $150 million aggregate liquidation value of the TIDES. Coltec has purchased call options on 2,865,744 shares of Goodrich common stock with an exercise price of $52.34 per share (the conversion price), which represents the total Goodrich shares that would be required if all TIDES holders convert. Until they expire in March 2007, the call options provide protection against the risk that the cash required to finance conversions of the TIDES could exceed the TIDES liquidation value. The call options are derivative instruments and are carried at fair value in the condensed consolidated balance sheets with changes in the fair value reflected currently in our earnings. Such changes may have a material effect on our results of operations in a given period, but will not result in any cash obligation.

          Goodrich offered to exchange new Goodrich debt securities for outstanding Coltec 7½% senior notes prior to the Distribution. Goodrich acquired $296.9 million of Coltec 7½% senior notes tendered pursuant to the offer. The $3.1 million of Coltec 7½% senior notes that remained outstanding following completion of the exchange offer continue to be obligations of Coltec.

          Our ability to raise capital through the issuance of additional equity is constrained because it may cause the Distribution to be taxable under Section 355(e) of the Internal Revenue Code and we have agreed to indemnify Goodrich for any tax due if our actions cause such a tax.

Contingencies

          General

          There are pending or threatened against EnPro or its subsidiaries various claims, lawsuits and administrative proceedings, all arising in the ordinary course of business with respect to commercial, product liability, asbestos and environmental matters, which seek remedies or damages. From time to time, we and our subsidiaries are also involved as plaintiffs in legal proceedings involving contract, patent protection, environmental and other matters. Gain contingencies, if any, are recognized when they are realized.

          Environmental

          Our facilities and operations are subject to federal, state and local environmental and occupational health and safety requirements of the U.S. and foreign countries. We take a proactive approach in addressing the applicability of all environmental, health and safety laws as they relate to our manufacturing operations and in proposing and implementing any remedial plans that may be necessary. We believe that we and our subsidiaries are in material compliance with all currently applicable regulations.

          We, or one of our subsidiaries, have been notified that we are among the potentially responsible parties under environmental laws for the cost of investigating and, in some cases, remediating

26


 

contamination by hazardous materials at 15 sites at which the costs to it are expected to exceed $100 thousand at each site. The majority of these sites relate to remediation projects at former operating facilities that have been sold or closed and primarily deal with soil and groundwater remediation. Investigations have been completed for 13 sites and are in progress at two sites. The laws governing investigation and remediation of these sites can impose joint and several liability for the associated costs. Liability for these costs can be imposed on present and former owners or operators of the properties or on parties that generated the wastes that contributed to the contamination. Our policy is to accrue environmental investigation and remediation costs when it is both probable that a liability has been incurred and the amount can be reasonably estimated. The measurement of the liability is based on an evaluation of currently available facts with respect to each individual situation and takes into consideration factors such as existing technology, presently enacted laws and regulations and prior experience in remediation of contaminated sites. Liabilities are provided for all sites based on the factors discussed above. As assessments and remediation progress at individual sites, these liabilities are reviewed periodically and adjusted to reflect additional technical data and legal information.

          We initiate corrective and preventive environmental projects in an effort to ensure safe and lawful operations at our facilities. We also conduct comprehensive compliance and management system audits at our facilities to maintain compliance and improve operational efficiency.

          At June 30, 2003, our balance sheet includes an accrued liability of $35.9 million for probable future expenditures relating to environmental sites. Although we are pursuing insurance recovery in connection with certain of these matters, no receivable has been recorded with respect to any potential recovery of costs in connection with any environmental matter.

          Actual costs to be incurred for identified situations in future periods may vary from estimates because of the inherent uncertainties in evaluating environmental exposures due to unknown conditions, changing government regulations and legal standards regarding liability. Subject to the imprecision in estimating future environmental costs, we believe that maintaining compliance with current environmental laws and government regulations will not require significant capital expenditures or have a material adverse effect on our financial condition or cash flows, but could be material to our results of operations in a given period.

          Colt Firearms and Central Moloney

          We have contingent liabilities related to divested businesses for which certain of our subsidiaries retained liability or are obligated under indemnity agreements. These contingent liabilities include, but are not limited to, potential product liability and associated claims related to Coltec’s former Colt Firearms subsidiary for firearms manufactured prior to 1990 and Coltec’s former Central Moloney subsidiary for electrical transformers manufactured prior to 1994. No material product liability claims are currently pending against Coltec related to Central Moloney or Colt Firearms. Colt Firearms has been named as a defendant in approximately 30 cases filed by municipalities seeking to recover costs arising from gun related injuries. Many of those cases have been dismissed or are inactive. Colt Firearms is seeking indemnification from Coltec for the remaining claims involving firearms manufactured prior to March 1990. We have rejected Colt Firearms’ claims for indemnification relating to the municipal gun cases in all instances on various legal grounds.

          Coltec also has ongoing obligations, which are included in retained liabilities of previously owned businesses in the condensed consolidated balance sheets, with regard to workers’ compensation, retiree medical and other retiree benefit matters that relate to Coltec’s periods of ownership of these operations.

27


 

          Crucible Materials Corporation

          We, through our Coltec subsidiary, own 44% of the outstanding common stock of Crucible Materials Corporation (“Crucible”) through an irrevocable non-voting trust (the “Ownership Trust”). Crucible, which is engaged primarily in the manufacture and distribution of high technology specialty metal products, was a wholly owned subsidiary of Coltec until 1985. The Ownership Trust expires in May 2004, at which time Coltec will own the Crucible stock directly. Under the terms of the Ownership Trust, Coltec has not participated in the management of Crucible’s affairs and we have exercised no influence over the ongoing activities and business strategies of Crucible.

          Based on an evaluation of the recoverability of our investment in Crucible’s common stock, the investment is valued at zero in our condensed consolidated balance sheets. In addition, due to the lack of any oversight of Crucible’s activities, and due to the uncertainty surrounding the future recoverability of our investment in Crucible, we do not include our proportionate share of Crucible’s net income (loss) in our results of operations.

          A portion of the remaining 56% of the shares of Crucible are owned by Crucible-sponsored pension and profit sharing plans and the Crucible Employee Stock Ownership Plan (“ESOP”). As Crucible’s employees retire, they are entitled to redeem those shares and be paid the fair value of the shares by Crucible. In addition, provided certain conditions are met, Crucible’s pension plans have the right to sell their shares of Crucible common stock to Crucible. When shares are purchased by Crucible, the shares are retired and Coltec’s percentage ownership in Crucible increases.

          If Coltec’s percentage ownership of Crucible’s common stock were ever to exceed 50%, Coltec would be deemed to be a “controlling person” with respect to the Crucible pension funds. As such, Coltec could be subject to certain liabilities with respect to Crucible’s pension obligations. If Crucible’s pension plans were to be terminated and the plans’ assets were not sufficient to cover the plans’ liabilities, Crucible and all members of its “controlled group” would be responsible for the unfunded termination liability. To the extent that Crucible could not fund any shortfall, Coltec could become responsible for funding the shortfall.

          The combined fair value of the assets in Crucible’s pension plans were approximately $20 million less than the accumulated benefit obligations at December 31, 2002. This amount is subject to change as the market value of the assets and interest rates fluctuate, as employees’ benefits change based on either plan amendments or additional credited service, and if contributions are made to the plans. In addition, in the event of a plan termination, the calculation of the actual termination liability would be based on more conservative interest rate assumptions and the deficit would likely be higher than the amount reflected above.

          Coltec’s ownership of Crucible’s common stock may never exceed 50% and Coltec may never become part of a “controlled group.” In addition, Crucible’s pension plans may never be terminated and Coltec may never bear any liability for any unfunded termination liability.

          In conjunction with the closure of a Crucible plant in the early 1980s, Coltec was required to fund two irrevocable trusts for retiree medical benefits for union employees at the plant. The first trust (the “Benefits Trust”) pays for these retiree medical benefits on an ongoing basis. Coltec has no continuing connection to the Benefits Trust, and thus the assets and liabilities of this trust are not included in our condensed consolidated balance sheets. Under the terms of the trust agreement, the trustees retained an actuary to assess the adequacy of the assets in the Benefits Trust in 1995, and another actuary report will be required in 2005 and 2015. No contributions were required as a result of the valuation in 1995. If, at

28


 

either or both of the future valuation dates, it is determined that the trust assets are not adequate to fund the payment of the medical benefits, Coltec will be required to contribute additional amounts. Based on preliminary information, an additional contribution might not be required in 2005. In the event there are ever excess assets in the Benefits Trust, those excess assets will not revert to Coltec.

          Because of the possibility of future contributions to the Benefits Trust, Coltec was required to establish a second trust (the “Back-Up Trust”) to cover potential shortfalls in the Benefits Trust. The assets and liabilities of the Back-Up Trust are reflected on our condensed consolidated balance sheets in other non-current assets and in retained liabilities of previously owned businesses, respectively, and amounted to $26.1 million each at June 30, 2003. If at the Benefits Trust review dates the actuary determines that there are excess assets in the Back-Up Trust, the excess assets will revert to Coltec based on a distribution formula and will be recorded in income upon receipt.

          Coltec also has ongoing obligations, which are included in retained liabilities of previously owned businesses in the condensed consolidated balance sheets, with regard to workers’ compensation, retiree medical and other retiree benefit matters, in addition to those mentioned previously, that relate to its ownership of these operations.

          Debt and Capital Lease Guarantees

          As of June 30, 2003, we had contingent liabilities for potential payments on guarantees of certain debt and lease obligations totaling $11.1 million. These guarantees arose from the divestiture of Crucible and Central Moloney and expire at various dates through 2010. There is no liability for these guarantees reflected in our condensed consolidated balance sheets. In the event that Crucible and Central Moloney do not fulfill their obligations under the debt and lease agreements, we could be responsible for these obligations.

          Asbestos

          History. Certain of Coltec’s subsidiaries, primarily Garlock Sealing Technologies, LLC (“Garlock”) and The Anchor Packing Company (“Anchor”), are among a number of defendants (typically 15 to 40 and sometimes more than 100) in actions filed in various states by plaintiffs alleging injury or death as a result of exposure to asbestos fibers. Except for claims against Garlock and Anchor, the number of claims to date has not been significant. Among the products at issue in these actions are industrial sealing products, predominantly gaskets and packing products, manufactured and/or sold by Garlock or Anchor. The damages claimed vary from action to action and in some cases plaintiffs seek both compensatory and punitive damages. To date, neither Garlock nor Anchor has been required to pay any punitive damage awards, although there can be no assurance that they will not be required to do so in the future. Liability for compensatory damages has historically been allocated among all responsible defendants, thus limiting the potential monetary impact of a particular judgment or settlement on any individual defendant. Since the first asbestos-related lawsuits were filed against Garlock in 1975, Garlock and Anchor have processed approximately 500,000 asbestos claims to conclusion (including judgments, settlements and dismissals) and, together with their insurers, have paid approximately $877 million in settlements and judgments at a cost in fees and expenses of an additional $283 million.

          Claims Mix. Of those claims resolved, approximately 2% have been claims of plaintiffs alleging the disease mesothelioma, approximately 6% have been claims of plaintiffs with lung or other cancers, and approximately 92% have been claims of plaintiffs alleging asbestosis, pleural plaques or other impairment of the respiratory system of varying degree. Because the more serious disease cases tend to work through the system more quickly than the non-malignancy cases and the cases filed by those who are not impaired, we believe that the disease mix in our current open caseload, on a percentage basis, is

29


 

even more skewed toward pleural plaques and includes a large number of claims made by plaintiffs who have suffered no disease and have no measurable impairment of any kind. In fact, while there are many cases in our current open caseload about which we have no disease information, we are aware of only approximately 7,000 that involve a claimant with mesothelioma, lung cancer or some other cancer.

          Product Defenses. We believe that Garlock and Anchor are in a favorable position compared to many other asbestos defendants because, among other things, the asbestos-containing products formerly sold by Garlock and Anchor were encapsulated, which means the asbestos fibers were incorporated into the product during the manufacturing process and sealed in a binder. They are also nonfriable, which means they cannot be crumbled by hand pressure. The Occupational Safety and Health Administration, which began generally requiring warnings on asbestos-containing products in 1972, has never required that a warning be placed on products such as Garlock’s gaskets. Notwithstanding that no warning label has been required, Garlock included one on all of its asbestos-containing products beginning in 1978. Further, gaskets such as those previously manufactured and sold by Garlock are one of the few asbestos-containing products still permitted to be manufactured under regulations of the Environmental Protection Agency. Since the mid-1980s, U.S. sales of asbestos-containing industrial sealing products have not been a material part of Garlock’s sales and sales of asbestos-containing products have been predominantly to sophisticated purchasers such as the U.S. Navy and large petrochemical facilities. These purchasers generally have extensive health and safety procedures and are familiar with the risks associated with the use and handling of industrial sealing products that contain asbestos. Garlock discontinued distributing asbestos-containing products in the U.S. during 2000 and worldwide in mid-2001.

          Since the beginning of 2003, Garlock’s product defenses enabled it to win defense verdicts in all three cases that it tried to verdict. Those trials were in California, Kentucky and Texas. In all three cases, the jury determined that Garlock’s products were not defective and that Garlock was not negligent.

          Settlements. Garlock settles and disposes of actions on a regular basis. In addition, some actions are disposed of at trial. Garlock’s historical settlement strategy has been to try to match the timing of payments with recoveries received from insurance, which, as described later, were limited to $80 million per year through the second quarter of 2003. However, in 1999 and 2000, Garlock implemented a short-term aggressive settlement strategy. The purpose of this short-term strategy was to achieve a permanent reduction in the number of overall asbestos claims through the settlement of a larger than normal number of claims, including some claims not yet filed as lawsuits. Mainly due to this short-term aggressive settlement strategy, but also because of a significant overall increase in claims filings, the settlement amounts paid in each of the years 1999 through 2002 were greater than the amounts paid in any year prior to 1999. In 2001, Garlock resumed its historical settlement strategy. In fact, Garlock reduced new settlement commitments from $180 million in 2000, to $94 million in 2001, and to $86 million in 2002. However, because of commitments made in 1999 and 2000 that will be paid over a number of years, the settlement amounts that Garlock will pay in 2003 through 2005 will continue to include amounts for settlements made during 1999, 2000 and early 2001.

          Settlements are made without any admission of liability and are generally made on a group basis with payments made to individual claimants over a period of one to four years. Settlement amounts vary depending upon a number of factors, including the jurisdiction where the action was brought, the nature and extent of the disease alleged and the associated medical evidence, the age and occupation of the plaintiff, the presence or absence of other possible causes of the plaintiff’s alleged illness, the availability of legal defenses, and whether the action is an individual one or part of a group. Garlock believes that its allocable portion of the total settlement amount for an action has typically ranged from 1% to 2% of the total amount paid by all defendants in the action.

          Before any payment on a settled claim is made, the claimant is required to submit a medical report acceptable to Garlock substantiating the asbestos-related illness and meeting specific criteria of

30


 

disability. In addition, sworn testimony or other evidence that the claimant worked with or around Garlock asbestos-containing products is required. The claimant is also required to sign a full and unconditional release of Garlock, its subsidiaries, parent, officers, directors, affiliates and related parties from any liability for asbestos-related injuries or claims.

          When a settlement demand is not reasonable given the totality of the circumstances, Garlock generally will try the case. Garlock has been successful in winning a substantial majority of the cases it has tried to verdict. Garlock’s share of adverse verdicts in these cases in the years 2000 through 2002 totaled approximately $6 million in the aggregate, and some of those verdicts are on appeal. As previously reported, Garlock won defense verdicts in all three cases it tried to verdict in the first six months of 2003.

          Status of Anchor. Anchor is an inactive and insolvent indirect subsidiary of Coltec. The insurance coverage available to Anchor of approximately $9 million as of June 30, 2003, is fully committed. Anchor continues to pay settlement amounts covered by its insurance but has not committed to settle any further actions since 1998. As cases reach the trial stage, Anchor is typically dismissed without payment.

          Insurance Coverage. The insurance coverage available to Garlock is substantial. As of June 30, 2003, Garlock had available $851 million of insurance coverage from carriers that it believes to be solvent. Garlock classifies $70 million of otherwise available insurance as insolvent. We believe Garlock will recover some of the insolvent insurance over time. In fact, Garlock recovered $2 million from an insolvent carrier during the year ended December 31, 2002, and $1.9 million during the first six months of 2003. Of the solvent insurance, $661 million (78%) is with US-based carriers whose credit rating by S&P is investment grade (BBB) or better, and whose AM Best rating is excellent (A-) or better, $63 million (7%) is with other solvent US carriers and $127 million (15%) is with various solvent London market carriers. Of the $851 million, $169 million is allocated to claims that have been paid by Garlock and submitted to its insurance companies for reimbursement and $94 million has been committed to claim settlements not yet paid by Garlock. Thus, at June 30, 2003, $588 million remained available for future asbestos-related settlements.

          Arrangements with Garlock’s insurance carriers limit the amount that can be received by it in any one year. The amount of insurance available to cover asbestos-related payments by Garlock was limited to $80 million per year through the second quarter of 2003. This limit automatically increases by 8% every three years. The next scheduled increase will impact recoveries beginning in the third quarter of 2003. Amounts paid by Garlock in excess of this annual limit that would otherwise be recoverable from insurance may be collected from the insurance companies in subsequent years so long as insurance is available, subject to the annual limit available in each subsequent year. As a result, Garlock is required to pay out of its own cash any amounts paid to settle or dispose of asbestos-related claims in excess of the annual limit and collect these amounts from its insurance carriers in subsequent years. To the extent that Garlock pays such amounts in a given year, these payments are recorded as a receivable. The amounts paid in excess of insurance recoveries thus far in 2003 that were recorded as a receivable amounted to $18.1 million. Garlock is pursuing various options, such as raising the annual limit and commuting policies at discounted values, to ensure as close a match as possible between payments by Garlock and recoveries received from insurance carriers. There can be no assurance that Garlock will be successful as to any or all of these options.

          Insurance coverage for asbestos claims is not available to cover exposures initially occurring on and after July 1, 1984. Garlock and Anchor continue to be named as defendants in new actions, a few of which allege initial exposure after July 1, 1984. To date, no payments have been made with respect to these claims, pursuant to a settlement or otherwise. In addition, Garlock and Anchor believe that they

31


 

have substantial defenses to these claims and therefore automatically reject them for settlement. However, there can be no assurance that any or all of these defenses will be successful in the future.

          Quantitative Claims Information. In accordance with internal procedures for the processing of asbestos product liability actions and due to the proximity to trial or settlement, certain outstanding actions against Garlock have progressed to a stage where we believe we can reasonably estimate the cost to dispose of these actions. These actions are classified as actions in advanced stages and the estimated costs to dispose of them are included in the table below. With respect to outstanding actions against Garlock that are in preliminary procedural stages, as well as any actions that may be filed in the future, we believe that insufficient information exists upon which judgments can be made as to the validity or ultimate disposition of such actions. Therefore, we believe that it is impossible to estimate with any degree of accuracy or reasonableness what, if any, potential liability or costs may be incurred. Accordingly, we have not included any estimate of future liability for such claims in the table below.

          We record an accrual for liabilities related to Garlock and Anchor asbestos-related matters that are deemed probable and can be reasonably estimated, which consist of settled claims and actions in advanced stages of processing. We also record an asset for the amount of those liabilities that we expect Garlock and Anchor to recover from insurance. A table is provided below depicting quantitatively the items discussed above.

                   
      As of and for the
      Six Months Ended
      June 30,
     
      2003   2002
     
 
(number of cases)
               
 
New Actions Filed During the Period (1)
    33,900       16,200  
 
Open Actions at Period-End (1)
    139,900       102,900  
(dollars in millions at period-end)
               
 
Estimated Amounts Recoverable from Insurance (2)
  $ 272.3     $ 347.0  
 
Estimated Liability for Settled Claims and Actions in Advanced Stages of Processing (3)
  $ 97.1     $ 181.3  
(dollars in millions)
               
 
Payments (4)
  $ 73.6     $ 80.4  
 
Insurance Recoveries (4)
    50.1       30.5  
 
 
   
     
 
 
Net Cash Flows
  $ (23.5 )   $ (49.9 )
 
 
   
     
 

  (1)   Consists only of actions actually filed with a court of competent jurisdiction. To the extent that a particular action names both Garlock and Anchor as defendants, for purposes of this table, the action is treated as a single action.
 
  (2)   At June 30, 2003, included $175.2 million representing cumulative payments made for which Garlock has not received a corresponding insurance recovery due to the annual limit imposed under Garlock’s insurance policies, and which will be recovered in future periods to the extent insurance is available. Also included at June 30, 2003, is $97.1 million representing amounts recoverable under insurance policies related to the estimated liability for settled claims and actions in advanced stages of processing. At June 30, 2003, we classified $88.1 million as a current asset and $184.2 million as a non-current asset in the condensed consolidated balance sheets.
 
  (3)   Includes amounts with respect to all claims committed in the period, whether or not an action has actually been filed with a court of competent jurisdiction. At June 30, 2003, we classified

32


 

      $55.9 million as a current liability and $41.2 million as a non-current liability in the condensed consolidated balance sheets.
 
  (4)   Includes amounts with respect to all payments for claims settlements and expenses and recoveries made in the period. In the six months ended June 30, 2003 and 2002, we added $18.1 million and $43.0 million, respectively, of the net cash flows to the asbestos insurance receivable in the condensed consolidated balance sheets, and we recorded $5.4 million and $7.0 million, respectively, as an expense in the condensed consolidated statements of operations.

          The number of new actions filed increased considerably from the first six months of 2002. We believe that the numbers were much higher than they otherwise would have been because of tort reform legislation passed last year in Mississippi and West Virginia and anticipated this year in Texas.

          Net cash flows for the first six months of 2002 were higher than the comparable amount in the first six months of 2003 partly due to the late receipt in 2002 of a scheduled insurance collection of approximately $15 million that was not received until July 2002.

          Strategy. Garlock’s current strategy is to focus on trial-listed cases and other cases in advanced stages of processing, to reduce new settlement commitments each year, and to proactively support legislative and other efforts aimed at asbestos reform. Garlock believes that this strategy should continue to result in the reduction of the negative annual cash flow impact from asbestos claims (as it has in 2003 compared to 2002 and 2002 compared to 2001), as previous settlements work their way through the payment process. Garlock believes that, as predicted in various epidemiological studies that are publicly available, the incidence of asbestos-related disease should decline steadily over the next decade and thereafter, so that the level of claims activity against Garlock will eventually decline to a level that can be paid from the cash flow expected from Garlock’s operations even if Garlock exhausts its insurance coverage. There can be no assurance that epidemiological predictions about incidence of asbestos-related disease will prove to be accurate, or that, even if they are, there will be a commensurate decline in the number of asbestos-related claims filings. In fact, such studies indicate that asbestos-related disease should be in decline currently, yet asbestos-related claims filings continue to increase.

          Considering the foregoing, as well as the experience of Coltec’s subsidiaries and other defendants in asbestos litigation, the likely sharing of judgments among multiple responsible defendants, recent bankruptcies of other defendants, and legislative efforts, and given the substantial amount of insurance coverage that Garlock expects to be available from its solvent carriers, we believe that pending actions against Garlock and Anchor are not likely to have a material adverse effect on our financial condition, but could be material to our results of operations or cash flows in a given period. We anticipate that asbestos-related actions will continue to be filed against Garlock. Because of the uncertainty as to the number and timing of potential future actions, as well as the amount that will have to be paid to settle or satisfy any such actions in the future, there can be no assurance that those future actions will not have a material adverse effect on our financial condition, results of operations and cash flows.

          Reform Legislation. The outlook for federal legislation to provide national asbestos litigation reform has improved during the first half of 2003. We are supportive generally of legislation pending in the Senate as long as it provides the certainty and finality to our liability for asbestos-related claims that it is intended to provide. The proposed legislation would set up a national trust fund as the exclusive means for the recovery of asbestos-related claims. We are not certain as to what contributions we would be required to make to such a trust, although we anticipate that they would be substantial and that they would continue for a significant number of years. While we are cautiously optimistic that proposed reform legislation ultimately will be adopted by the U.S. Congress, there is no assurance that the proposed bill or any other asbestos legislation will ultimately become law.

33


 

New Accounting Pronouncements

          In January 2003, FASB Interpretation No. 46 (“FIN 46”), “Consolidation of Variable Interest Entities,” was issued. The interpretation provides guidance on consolidating variable interest entities and applies immediately to variable interests created or obtained after January 31, 2003. The guidelines of the interpretation will become applicable to us in our third quarter 2003 financial statements for variable interest entities acquired before February 1, 2003. The interpretation requires variable interest entities to be consolidated if the equity investment at risk is not sufficient to permit an entity to finance its activities without support from other parties or the equity investors lack certain specified characteristics. We are reviewing FIN 46 to determine its impact, if any, on future reporting periods.

          In May 2003, Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity” (“SFAS 150”), was issued. SFAS 150 establishes standards for classifying and measuring as liabilities certain financial instruments that embody obligations of the Company and have characteristics of both liabilities and equity. SFAS 150 must be applied immediately to instruments entered into or modified after May 31, 2003, and will become applicable to us in our third quarter 2003 financial statements for all other pre-existing instruments. Since the TIDES are primarily convertible into Goodrich common stock, they are not within the scope of SFAS 150.

Outlook

          Our strong liquidity and relatively conservative leverage give us the sound financial position we need to build a stronger EnPro. In the short time we have been an independent company, we have made progress in our strategy to improve operating efficiency and the management of asbestos settlements by our subsidiaries. Going forward, we remain focused on these issues as we seek to expand our product offerings and customer base and to strengthen the mix of our businesses to ensure our long-term viability.

          Though we do not expect significant improvement in our markets for the remainder of 2003, we do expect to continue to benefit from improved performance by our operations. For the full year, we continue to expect a modest increase in sales over 2002, as new products are introduced and sales efforts continue to expand. Higher volume and the benefits of the company’s Total Customer Value, or TCV, lean enterprise program should lead to improved operating margins and increased profitability for the year compared to 2002.

          We anticipate that cash flow in 2003 will benefit from lower net asbestos payments and improved operating income. However, we expect capital spending in 2003 to increase over 2002 as we implement programs to reduce costs and improve market penetration.

Forward-Looking Information

          This Quarterly Report on Form 10-Q includes statements that reflect projections or expectations of the future financial condition, results of operations and business of EnPro that are subject to risk and uncertainty. We believe those statements to be “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this document, the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “should,” “could,” “would” or “may” and similar expressions may identify forward-looking statements.

          We cannot guarantee that actual results or events will not differ materially from those projected, estimated or anticipated in any of the forward-looking statements contained in this document. In addition to those factors specifically noted in the forward-looking statements and those identified in the

34


 

Company’s annual report on Form 10-K for the year ended December 31, 2002, other important factors that could result in those differences include:

    the resolution of current and potential future asbestos claims against certain of our subsidiaries which depends on such factors as the possibility of asbestos reform legislation, the financial viability of insurance carriers, the timing of payout of claims, limitations on the amount that may be recovered from insurance carriers, the bankruptcies of other defendants and the results of litigation;
 
    general economic conditions in the markets served by our businesses, some of which are cyclical and experience periodic downturns; and
 
    the amount of any payments required to satisfy contingent liabilities related to previously divested businesses, including liabilities for certain products, environmental matters, guaranteed debt and lease payments, employee benefit obligations and other matters.

          We caution our shareholders not to place undue reliance on these statements, which speak only as of the date on which such statements were made.

          Whenever you read or hear any subsequent written or oral forward-looking statements attributed to us or any person acting on our behalf, you should keep in mind the cautionary statements contained or referred to in this section. We do not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events.

35


 

PART I, ITEM 3.

ENPRO INDUSTRIES, INC.

QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK

          We are exposed to certain market risks as part of our ongoing business operations, including risks from changes in interest rates and foreign currency exchange rates that could impact our financial condition, results of operations and cash flows. We manage our exposure to these and other market risks through regular operating and financing activities, and through the use of derivative financial instruments. We use such derivative financial instruments as risk management tools and not for speculative investment purposes. For information about our interest rate risk and foreign currency risk, see “Quantitative and Qualitative Disclosures about Market Risk” in our annual report on Form 10-K for the fiscal year ended December 31, 2002.

Foreign Currency Risk

          We are exposed to foreign currency risks that arise from normal business operations. These risks include the translation of local currency balances of our foreign subsidiaries, intercompany loans with foreign subsidiaries and transactions denominated in foreign currencies. Our objective is to minimize our exposure to these risks through our normal operating activities and, where appropriate, through foreign currency forward contracts and option contracts.

Risk Due to Convertibility of TIDES

          As described in the preceding “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Capital Resources” section, Coltec purchased call options that expire in March 2007 to provide protection against the risk that the cash required to finance conversions of the TIDES could exceed the TIDES liquidation value. While Coltec has hedged its exposure to conversion costs in excess of the aggregate liquidation value of the TIDES, we cannot be certain that Coltec will have the financial resources to redeem these securities or effectively hedge this exposure beyond the term of the call options.

          The call options are derivative instruments and are carried at fair value in our condensed consolidated balance sheets with changes in the fair value reflected in our earnings. Such changes may have a material effect on our results of operations in a given period, but will not result in any cash obligation. If the call options expire unexercised and the market price of Goodrich common stock at that time is less than the exercise price per share, then the cumulative net charges to earnings over the life of the call options for financial reporting purposes will be limited to the cost of the call options.

36


 

PART I, ITEM 4.

ENPRO INDUSTRIES, INC.

CONTROLS AND PROCEDURES

          As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective in timely alerting them to material information required to be included in our periodic reports filed with the Securities and Exchange Commission. It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. In addition, no change in our internal control over financial reporting has occurred during, or subsequent to, the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

37


 

PART II, ITEM 1.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

          A description of legal, environmental and asbestos matters is included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Contingencies.”

          In addition to the matters noted above, we are from time to time subject to and are presently involved in, other litigation and legal proceedings arising out of the ordinary course of business. We believe that the outcome of such other litigation and legal proceedings will not have a material adverse affect on our financial condition, results of operations and cash flows.

Item 6. Exhibits and Reports on Form 8-K.

  (a)   Exhibits

          The exhibits to this Report on Form 10-Q are listed in the accompanying Exhibit Index.

  (b)   Reports on Form 8-K

       A report on Form 8-K was furnished to the Securities and Exchange Commission on April 24, 2003, relating to the announcement of the Company’s earnings for the quarter ended March 31, 2003.

38


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Charlotte, North Carolina on this 14th day of August, 2003.

         
    ENPRO INDUSTRIES, INC.
         
    By:         /s/ Richard L. Magee
       
        Richard L. Magee
        Senior Vice President, General Counsel and
        Secretary
         
    By:         /s/ Donald G. Pomeroy II
       
        Donald G. Pomeroy II
        Vice President and Controller
        (Chief Accounting Officer)

39


 

EXHIBIT INDEX

  Distribution Agreement between Goodrich Corporation, EnPro Industries, Inc. and Coltec Industries Inc (incorporated by reference to Exhibit 2 to the Form 10-Q for the quarter ended June 30, 2002 filed by EnPro Industries, Inc.)
 
3.1   Restated Articles of Incorporation of EnPro Industries, Inc., as amended (incorporated by reference to Exhibits 4.3 and 4.4 to the Registration Statement on Form S-8 filed by EnPro Industries, Inc., the EnPro Industries, Inc. Retirement Savings Plan for Hourly Workers and the EnPro Industries, Inc. Retirement Savings Plan for Salaried Workers (File No. 333-89576))
 
3.2   Amended Bylaws of EnPro Industries, Inc. (incorporated by reference to Exhibit 4.5 to the Registration Statement on Form S-8 filed by EnPro Industries, Inc., the EnPro Industries, Inc. Retirement Savings Plan for Hourly Workers and the EnPro Industries, Inc. Retirement Savings Plan for Salaried Workers (File No. 333-89576))
 
4.1   Form of certificate representing shares of common stock, par value $0.01 per share, of EnPro Industries, Inc. (incorporated by reference to Amendment No. 4 of the Registration Statement on Form 10 of EnPro Industries, Inc. (File No. 001-31225))
 
4.2   Rights Agreement between EnPro Industries, Inc. and The Bank of New York, as rights agent (incorporated by reference to Exhibit 4.7 to the Registration Statement on Form S-8 filed by EnPro Industries, Inc., the EnPro Industries, Inc. Retirement Savings Plan for Hourly Workers and the EnPro Industries, Inc. Retirement Savings Plan for Salaried Workers (File No. 333-89576))
 
4.3   Certificate of Trust of Coltec Capital Trust (incorporated by reference to Exhibit 4.1 to Coltec Industries Inc’s Registration Statement on Form S-3 (File No. 333-52975))
 
4.4   Amended and Restated Declaration of Trust of Coltec Capital Trust dated as of April 14, 1998, among Coltec Industries Inc, as Sponsor, The Bank of New York, as Property Trustee, and The Bank of New York (Delaware), as Delaware Trustee and the individuals named therein as Administrative Trustees (incorporated by reference to Exhibit 4.2 to Coltec Industries Inc’s Registration Statement on Form S-3 (File No. 333-52975))
 
4.5   Form of 5¼% Convertible Preferred Securities (included in Exhibit 4.4 above)
 
4.6   Indenture dated as of April 14, 1998, between Coltec Industries Inc and The Bank of New York, as Trustee, relating to the 5¼% Convertible Junior Subordinated Deferrable Interest Debentures due 2028 (incorporated by reference to Exhibit 4.3 to Coltec Industries Inc’s Registration Statement on Form S-3 (File No. 333-52975))
 
4.7   First Supplemental Indenture, dated as of July 12, 1999, between The B.F. Goodrich Company and The Bank of New York, as trustee (incorporated by reference to Amendment No. 1 of the Registration Statement on Form 10 of EnPro Industries, Inc. (File No. 001-31225))
 
4.8   Form of 5¼% Convertible Junior Subordinated Deferrable Interest Debenture Due 2028 (included in Exhibit 4.6 above)

1


 

4.9   Guarantee Agreement, dated as of April 14, 1998, between Coltec Industries Inc and The Bank of New York, as Trustee (incorporated by reference to Exhibit 4.6 to Coltec Industries Inc’s Registration Statement on Form S-3 (No. 333-52975))
 
4.10   Guarantee Agreement, dated as of July 12, 1999, between The B.F. Goodrich Company and The Bank of New York, as trustee (incorporated by reference to Amendment No. 1 of the Registration Statement on Form 10 of EnPro Industries, Inc. (File No. 001-31225))
 
4.11   Guarantee Agreement, dated as of May 31, 2002, between EnPro Industries, Inc. and The Bank of New York, as trustee (incorporated by reference to Exhibit 4.11 to the Form 10-K for the year ended December 31, 2002 filed by EnPro Industries, Inc.)
 
4.12   Second Supplemental Indenture, dated as of May 31, 2002, among Coltec Industries Inc, EnPro Industries, Inc., Goodrich Corporation and The Bank of New York, as trustee (incorporated by reference to Exhibit 4.12 to the Form 10-K for the year ended December 31, 2002 filed by EnPro Industries, Inc.)
 
4.13   Indenture dated as of April 16, 1998, between Coltec Industries Inc and Bankers Trust Company as Trustee, relating to the Coltec Industries Inc 7½% Senior Notes due 2008 (incorporated by reference to Exhibit 4.1 to Coltec Industries Inc’s Registration Statement on Form S-4 (File No. 333-53005))
 
4.14   Form of 7½% Senior Note due 2008 (included in Exhibit 4.13 above)
 
31.1*   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
31.2*   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
32*   Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


*   Filed herewith

2